Management of patients with von Willebrand disease: practice of St.Petersburg City Hemophilia Care Centre
Von Willebrand disease (vWD) is a heritable disease, which can be inherited by either autosomal dominant or autosomal recessive, caused by qualitative or quantitative deficiency of von Willebrand factor (vWF) and characterized by excessive bleeding. In Russia 2013 was announced as a year of von Willebrand disease. For elaboration of guidelines on improvement of specific care of children and adults suffering from vWD we carried out a retrospective study. Information regarding the patients registered by regional haematologists with diagnosis of vWD (ICH-10 code D 68.0) was collected. There were examined 86 patients suspected for vWD. The diagnosis was confirmed in 52 (61.6%) patients. This data supported opinion that present status of laboratory service in the Russian regions is not satisfactory for detection of coagulation disorders and final diagnosis justification. Factor VIII concentrate is relatively novel but rare for Russian practice therapeutic approach for bleeding treatment in the patients with vWD. According to the results of the study it was effective in all the cases.
About the authorsAndreeva Tatiana A.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Occupational Health. 1992. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3376487\nhttp://www.worldcat.org/isbn/9241544198\nhttp://apps.who.int/classifications/icd10/browse/2010/en
Ruggeri Z.M., Zimmerman T.S. Variant von Willebrand’s disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J. Clin. Invest. 1980; 65(6): 1318-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6773982
Vischer U.M., Wagner D.D. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 1994; 83(12): 3536-44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8204880
Savage B., Saldívar E., Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996; 84(2): 289-97. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8565074
Kuwano A., Morimoto Y., Nagai T., Fukushima Y., Ohashi H., Hasegawa T., et al. Precise chromosomal locations of the genes for dentatorubralpallidoluysian atrophy (DRPLA), von Willebrand factor (F8vWF) and parathyroid hormone-like hormone (PTHLH) in human chromosome 12p by deletion mapping. Hum. Genet. 1996; 97(1): 95-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8557270
Kujovich J.L. von Willebrand’s disease and menorrhagia: prevalence, diagnosis, and management. Am. J. Hematol. 2005; 79(3): 220-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15981234
Kirtava A., Drews C., Lally C., Dilley A., Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand’s disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia. 2003; 9(3): 292-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12694520
Conti M., Mari D., Conti E., Muggiasca M.L., Mannucci P.M. Pregnancy in women with different types of von Willebrand disease. Obstet. Gynecol. 1986; 68(2): 282-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3090493
Greer I.A., Lowe G.D., Walker J.J., Forbes C.D. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br. J. Obstet. Gynaecol. 1991; 98(9): 909-18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1911610
- Refbacks are not listed
Контент доступен под лицензией Creative Commons Attribution 3.0 License.